Can ozone gas help heal diabetic foot wounds?
NCT ID NCT05977309
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether applying ozone gas to diabetic foot ulcers helps them heal faster. 430 people with diabetic foot ulcers received either standard wound care plus ozone therapy or standard care alone. The treatment was given every three days for a total of eight sessions. The study measured wound size, skin oxygen levels, and infection to see if ozone made a difference.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- topical ozone therapy (device)
- What this could lead to
- If it works, this could offer a simple, low-cost addition to standard wound care for diabetic foot ulcers.
- What could go wrong
- This is a single completed trial with mixed evidence. Ozone therapy may not speed healing and could cause skin irritation or other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
430 people
The number who actually took part.
- Started
-
Aug 2023
- Finished
-
Dec 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion standarts: * Patients with diabetic foot ulcers, both male and female, include both sexes. * Size wound 4-80cm * Value toe brachial index between 4-7 mmHg * Value transcutaneous oxygen (TcPO2) levels range 1-45 mmHg * Infection, area of cellulitis 1-2cm Exclusion standarts: * Immunodeficiency conditions * Concurent ilness * Size wound \>80cm * Value toe brachial index (TBI) \<4 mmHg * Value crititcal for transcutaneous oxygen (TcPO2) is 0 mmHg * Systemic infection and sepsis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetic foot ulcer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Griya Husada Clinic
Kediri, Indonesia, 64118, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy shots aim to save legs from amputation in diabetes
- New wound dressing put to the test against diabetic foot ulcers
- Silver and sound: can ultrasound push nanoparticles into diabetic wounds?
- Zapping a leg nerve: can a wearable device help stubborn ulcers heal?
- Wound dressings that trap microbes: scientists test a Drug-Free approach
- Can a traditional herbal mix save limbs from diabetic ulcers?